Literature DB >> 2886305

Diazepam metabolism in cultured hepatocytes from rat, rabbit, dog, guinea pig, and man.

R J Chenery, A Ayrton, H G Oldham, P Standring, S J Norman, T Seddon, R Kirby.   

Abstract

Diazepam metabolism has been investigated in cultured hepatocytes from rat, rabbit, dog, guinea pig, and man. The metabolite profile obtained by HPLC analysis of the culture medium indicated that substantial differences exist corresponding to known species differences in the metabolite profile of diazepam in vivo. These differences were attributed to a combination of the rate at which a metabolite was formed and the rate at which it is removed from the medium by further metabolism. The intrinsic clearance of nordiazepam in hepatocytes from each of the species exhibited the most marked species variation (rat much greater than guinea pig greater than rabbit greater than human greater than dog). Species that exhibited a high intrinsic clearance for nordiazepam were also those species that exhibited significant hydroxylation at the 4'-site of the molecule. The disappearance of diazepam was rapid in rat, dog, and guinea pig hepatocytes, but slow in human hepatocytes. Moreover, rat and human hepatocytes exhibited different saturability of diazepam clearance with respect to diazepam concentration accounting, at least in part, for the different rates of diazepam metabolism in the different species. These results support the value of hepatocytes in drug metabolism studies and especially in studies of species differences in metabolism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2886305

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  7 in total

1.  Cell culture systems and in vitro toxicity testing. Technical report no. 4 of the Johns Hopkins Center for Alternatives to Animal Testing (CAAT): technical workshop of June 13-15, 1990.

Authors: 
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

Review 2.  Scaffold-hopping as a strategy to address metabolic liabilities of aromatic compounds.

Authors:  Phillip R Lazzara; Terry W Moore
Journal:  RSC Med Chem       Date:  2019-12-16

3.  Nutrient plasma levels achieved during treatment that reduces noise-induced hearing loss.

Authors:  Colleen G Le Prell; David F Dolan; David C Bennett; Peter A Boxer
Journal:  Transl Res       Date:  2011-03-09       Impact factor: 7.012

4.  Determination of minimal steady-state plasma level of diazepam causing seizure threshold elevation in rats.

Authors:  Ashish Dhir; Michael A Rogawski
Journal:  Epilepsia       Date:  2018-04-06       Impact factor: 5.864

Review 5.  Human hepatocytes as a key in vitro model to improve preclinical drug development.

Authors:  G Fabre; J Combalbert; Y Berger; J P Cano
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

Review 6.  Liver cell models in in vitro toxicology.

Authors:  A Guillouzo
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

7.  Characterization of Pharmacokinetics in the Göttingen Minipig with Reference Human Drugs: An In Vitro and In Vivo Approach.

Authors:  Floriane Lignet; Eva Sherbetjian; Nicole Kratochwil; Russell Jones; Claudia Suenderhauf; Michael B Otteneder; Thomas Singer; Neil Parrott
Journal:  Pharm Res       Date:  2016-07-28       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.